{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/43388"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/43388","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Nicotinamide dinucleotide modulates DNA methylation and gene transcription","abstract":"Poly (ADP-Riboysl) Polymerase 1 (PARP1) is a versatile protein that plays a key role in directing epigenetic pathways in cells by using nicotinamide adenine dinucleotide (NAD) as a substrate. We demonstrate that PARP1-directed adenine diphosphate (ADP) ribosylation impairs DNA Methyltransferase 1 (DNMT1) enzymatic activity by an NAD-promoted mechanism. This leads to demethylation of DNA, and thus reactivation of the CCAAT/enhancer-binding protein alpha (CEBPA) gene, suggesting the presence of a previously unknown NAD-modulated region within the locus. As an important tumor suppressor gene, epigenetic reactivation of CEPBA suggests possible therapeutic treatments for diseases associated with CEPBA suppression, such as many cancers.","abstract_html":"Poly (ADP-Riboysl) Polymerase 1 (PARP1) is a versatile protein that plays a key role in directing epigenetic pathways in cells by using nicotinamide adenine dinucleotide (NAD) as a substrate. We demonstrate that PARP1-directed adenine diphosphate (ADP) ribosylation impairs DNA Methyltransferase 1 (DNMT1) enzymatic activity by an NAD-promoted mechanism. This leads to demethylation of DNA, and thus reactivation of the CCAAT/enhancer-binding protein alpha (CEBPA) gene, suggesting the presence of a previously unknown NAD-modulated region within the locus. As an important tumor suppressor gene, epigenetic reactivation of CEPBA suggests possible therapeutic treatments for diseases associated with CEPBA suppression, such as many cancers.","abstract_has_math":false,"creators":["Hausman, Clinton"],"institution":"Boston University","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Medical Sciences","degree_department":null,"school":null,"contributors":[],"advisors":["McKnight, C. James"],"committee_chairs":[],"committee_members":[],"year":2021,"date_issued":"2021","date_published":"2021","updated_at":"2026-11-19T02:41:40Z","subjects":["Biology"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/43388","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/43388","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F43388","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["McKnight, C. James"]},{"key":"dc:creator","label":"Author","values":["Hausman, Clinton"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2021-11-22T18:51:17Z"]},{"key":"dc:date.embargo","label":"Dc Date Embargo","values":["2023-11-18T00:00:00Z"]},{"key":"dc:date.issued","label":"Date","values":["2021"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2021-11-18T20:02:49Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/43388"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Poly (ADP-Riboysl) Polymerase 1 (PARP1) is a versatile protein that plays a key role in directing epigenetic pathways in cells by using nicotinamide adenine dinucleotide (NAD) as a substrate. We demonstrate that PARP1-directed adenine diphosphate (ADP) ribosylation impairs DNA Methyltransferase 1 (DNMT1) enzymatic activity by an NAD-promoted mechanism. This leads to demethylation of DNA, and thus reactivation of the CCAAT/enhancer-binding protein alpha (CEBPA) gene, suggesting the presence of a previously unknown NAD-modulated region within the locus. As an important tumor suppressor gene, epigenetic reactivation of CEPBA suggests possible therapeutic treatments for diseases associated with CEPBA suppression, such as many cancers."]},{"key":"dc:title","label":"Title","values":["Nicotinamide dinucleotide modulates DNA methylation and gene transcription"]}]}],"canonical_facts":{"dc:contributor.advisor":["McKnight, C. James"],"dc:creator":["Hausman, Clinton"],"dc:date.accessioned":["2021-11-22T18:51:17Z"],"dc:date.embargo":["2023-11-18T00:00:00Z"],"dc:date.issued":["2021"],"dc:date.updated":["2021-11-18T20:02:49Z"],"dc:description.abstract":["Poly (ADP-Riboysl) Polymerase 1 (PARP1) is a versatile protein that plays a key role in directing epigenetic pathways in cells by using nicotinamide adenine dinucleotide (NAD) as a substrate. We demonstrate that PARP1-directed adenine diphosphate (ADP) ribosylation impairs DNA Methyltransferase 1 (DNMT1) enzymatic activity by an NAD-promoted mechanism. This leads to demethylation of DNA, and thus reactivation of the CCAAT/enhancer-binding protein alpha (CEBPA) gene, suggesting the presence of a previously unknown NAD-modulated region within the locus. As an important tumor suppressor gene, epigenetic reactivation of CEPBA suggests possible therapeutic treatments for diseases associated with CEPBA suppression, such as many cancers."],"dc:identifier.uri":["https://hdl.handle.net/2144/43388"],"dc:language.iso":["en_US"],"dc:subject":["Biology"],"dc:title":["Nicotinamide dinucleotide modulates DNA methylation and gene transcription"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Medical Sciences"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-19T02:41:40Z"}